Morning Market Losers By: Benzinga via Benzinga July 01, 2014 at 09:46 AM EDT Synageva BioPharma (NASDAQ: GEVA) shares tumbled 8.22% to $96.19 after the company reported that Phase 3 study met primary endpoint and ... Read More >> Related Stocks: Acuity Brands Inc Generac Holdings Inc Urban Outfitters Western Gas Eqty Partners LP